Loading…
Company's innovative medical device technology gains further protection.
Nuwellis, Inc. (Nasdaq: NUWE) announced the granting of a new patent for its innovative medical device technology. The announcement led to an increase in the company's stock price.
The new patent provides additional intellectual property protection for Nuwellis's technology, enhancing its competitive position in the medical device industry. The stock price increase reflects investor confidence in the company's continued innovation and market potential.
As of the latest available data, Nuwellis has a free float of 1,632,300 shares and 902,660 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.